Service Offering: scale-X™ carbo bioreactor system
Univercells Technologies provides reliable service solutions and quality support & maintenance to help you maintain performance and maximum safety of the equipment.
DownloadLibrary
Discover our publications
scale-X™ hydro bioreactor for early process development
The scale-X hydro bioreactor is a small-scale, single-use, structured fixed-bed bioreactor enabling direct process transfer from existing processing technology for rapid proof of concept within a reduced footprint.
DownloadPromising Vero cell growth in scale-X™ bioreactors
Case study comparing adherent Vero cell growth on microcarriers and intensified, fixed-bed scale-X bioreactors hydro (2.4 m²) and carbo (10-30 m²). Results demonstrate the scale-X bioreactors as a suitable alternative to traditional technologies.
Learn moreNevoLine™ Upstream Platform: Integrated and Automated Solution for Intensified Virus Manufacturing
The NevoLine™ Upstream system is a high-performance and automated platform for commercial virus manufacturing. It integrates all process steps from inoculation to midstream processing to deliver a ready for downstream bulk.
DownloadHow one CDMO used innovative technology to overcome viral vaccine production challenges?
Discover how Ology Biosciences is leveraging Univercells Technologies’ intensified fixed-bed bioreactor and bioprocessing expertise to bring vaccine production to the next level. Get case study results and expert insights on how to find success with adherent-cell growth profiles and viral performance to produce viral vaccines using the scale-X bioreactors.
Visit siteIntensified & automated biomanufacturing technologies for gene therapies production
The scale-X™ bioreactor range and the NevoLine™ platform: integrated and automated solutions for an intensified AAV and Lentiviral vectors manufacturing.
DownloadDevelopment of a scalable manufacturing platform for viral vectors
A case study on AAV and Adenovirus vectors presented at ASGCT 23rd Annual meeting 2020 by our Deputy CTO, Tania Pereira Chilima
DownloadThe NevoLine™ platform concept – developed by Univercells
Poster illustrates the key features, benefits and applications of the NevoLine concept with the emphasis on the first implementation of this approach – The NevoLine platform for trivalent polio vaccine (sIPV).
DownloadHomogenous HEK293 cell growth in scale-X™ bioreactor
Proof of concept for scalable adherent cell growth and adenovirus production
Learn morescale-X™ carbo bioreactor system for rapid process development
The scale-X™ carbo system is a bench-scale automated cell culture system for expression and concentration of viral drug substance, suited for rapid process development and cost-effective clinical production.
DownloadNevoLine™ sIPV platform: proof of concept – developed by Univercells
The NevoLine sIPV platform was designed and developed by Univercells as part of a $12M Grand Challenges grant awarded by the Bill & Melinda Gates Foundation. This proof of concept was developed to deliver affordable inactivated polio vaccine (sIPV) in a low footprint.
DownloadDisruptive micro-facility – developed by Univercells
Poster presents the NevoLine concept to deliver affordable vaccine doses based on sIPV polio vaccine case study.
Download